_version_ 1784696880185212928
author Mangaonkar, Abhishek A.
Lasho, Terra L.
Finke, Christy
Ketterling, Rhett P.
Reichard, Kaaren K.
McCullough, Kristen
Gangat, Naseema
Al-Kali, Aref
Begna, Kebede H.
Hogan, William H.
Litzow, Mark R.
Alkhateeb, Hassan
Shah, Mithun
Pardanani, Animesh
Tefferi, Ayalew
Al Ali, Najla H.
Talati, Chetasi
Sallman, David
Padron, Eric
Komrokji, Rami
Patnaik, Mrinal M.
author_facet Mangaonkar, Abhishek A.
Lasho, Terra L.
Finke, Christy
Ketterling, Rhett P.
Reichard, Kaaren K.
McCullough, Kristen
Gangat, Naseema
Al-Kali, Aref
Begna, Kebede H.
Hogan, William H.
Litzow, Mark R.
Alkhateeb, Hassan
Shah, Mithun
Pardanani, Animesh
Tefferi, Ayalew
Al Ali, Najla H.
Talati, Chetasi
Sallman, David
Padron, Eric
Komrokji, Rami
Patnaik, Mrinal M.
author_sort Mangaonkar, Abhishek A.
collection PubMed
description
format Online
Article
Text
id pubmed-9052897
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-90528972022-05-13 SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity Mangaonkar, Abhishek A. Lasho, Terra L. Finke, Christy Ketterling, Rhett P. Reichard, Kaaren K. McCullough, Kristen Gangat, Naseema Al-Kali, Aref Begna, Kebede H. Hogan, William H. Litzow, Mark R. Alkhateeb, Hassan Shah, Mithun Pardanani, Animesh Tefferi, Ayalew Al Ali, Najla H. Talati, Chetasi Sallman, David Padron, Eric Komrokji, Rami Patnaik, Mrinal M. Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-02-10 /pmc/articles/PMC9052897/ /pubmed/35142154 http://dx.doi.org/10.3324/haematol.2021.280463 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Mangaonkar, Abhishek A.
Lasho, Terra L.
Finke, Christy
Ketterling, Rhett P.
Reichard, Kaaren K.
McCullough, Kristen
Gangat, Naseema
Al-Kali, Aref
Begna, Kebede H.
Hogan, William H.
Litzow, Mark R.
Alkhateeb, Hassan
Shah, Mithun
Pardanani, Animesh
Tefferi, Ayalew
Al Ali, Najla H.
Talati, Chetasi
Sallman, David
Padron, Eric
Komrokji, Rami
Patnaik, Mrinal M.
SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
title SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
title_full SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
title_fullStr SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
title_full_unstemmed SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
title_short SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
title_sort sf3b1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052897/
https://www.ncbi.nlm.nih.gov/pubmed/35142154
http://dx.doi.org/10.3324/haematol.2021.280463
work_keys_str_mv AT mangaonkarabhisheka sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT lashoterral sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT finkechristy sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT ketterlingrhettp sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT reichardkaarenk sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT mcculloughkristen sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT gangatnaseema sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT alkaliaref sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT begnakebedeh sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT hoganwilliamh sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT litzowmarkr sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT alkhateebhassan sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT shahmithun sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT pardananianimesh sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT tefferiayalew sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT alalinajlah sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT talatichetasi sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT sallmandavid sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT padroneric sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT komrokjirami sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity
AT patnaikmrinalm sf3b1mutantmyelodysplasticsyndromemyeloproliferativeneoplasmsauniquemolecularandprognosticentity